Molly Nozyce, PhD
Dr. Nozyce is the Director of the Division of Developmental Pediatrics. Dr Nozyce is an Associate Professor of Pediatrics at the Albert Einstein College of Medicine.
New School for Social Research
Yeshiva University, Ferkauf Graduate School of Psychology, PhD
- Internship: Albert Einstein College of Medicine
- Developmental-Behavioral Fellowship: Bronx Developmental Center
- Malee KM, Chernoff MC, Nozyce ML, et al; Memory and Executive Functioning Study of the Pediatric HIV/AIDS Cohort Study. Impact of Perinatally Acquired HIV Disease Upon Longitudinal Changes in Memory and Executive Functioning. J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):455-464.
- Sirois PA, Chernoff MC, Nozyce ML, et al; Memory and Executive Functioning Study of the Pediatric HIV/AIDS Cohort Study. Associations of Memory and Executive Functioning With Academic and Adaptive Functioning Among Youth With Perinatal HIV Exposure and/or Infection. J Pediatric Infect Dis Soc. 2016 Dec;5(suppl 1):S24-S32.
- Van Dyke RB, Wiznia A, Nozyce M, et al. Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV. Clin Infect Dis. 2016 Jul 1;63(1):133-137.
- Sirois PA, Aaron L, Nozyce ML, et al; IMPAACTPACTG 219C Team. Stimulant Medications and Cognition, Behavior and Quality of Life in Children and Youth with HIV. Pediatr Infect Dis J. 2016 Jan;35(1):e12-8.
- Purswani MU; Pediatric HIV/AIDS Cohort Study (PHACS), Wiznia A, Nozyce M, et al. Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection. Clin Infect Dis. 2016 Jan 1;62(1):106-114.
- Nozyce ML, Huo Y, Williams PL, et al; Pediatric HIVAIDS Cohort Study. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age. Pediatr Infect Dis J. 2014 Nov;33(11):1128-33.
- Grant R, Nozyce M. Proposed changes to the American Psychiatric Association diagnostic criteria for autism spectrum disorder: implications for young children and their families. Matern Child Health J. 2013 May;17(4):586-92.
- Sirois PA, Huo Y, Nozyce ML; Pediatric HIVAIDS Cohort Study. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J. 2013 Jun;32(6):648-55.
- Miller TI, Borkowsky W, Nozyce M, et al. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med. 2012 May;13(5):264-75.
- Kapetanovic S, Aaron L, Nozyce ML, et al; Pediatric AIDS Clinical Trials. The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV. AIDS Patient Care STDS. 2009 Nov;23(11):939-47.
- Sirois PA, Montepiedra G, Nozyce ML; IMPAACT/PACTG 219C Team. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV. J Dev Behav Pediatr. 2009 Oct;30(5):403-12.
- Nozyce ML, Lee SS, Wiznia A, et al: A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 2006;117:763-70.
- Jeremy RJ, Kim S, Nozyce M, et al: Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005;115:380-7.
- Pearson DA, McGrath NM, Nozyce M, et al: Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatrics 2000;106:E76.
- Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M, Nozyce M, et al: Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatrics 1999;104:e32.